5D Library › Biomathematical Models of Sub-Perceptual Tryptamine Pharmacokinetics, 5-HT2A Receptor Desensitisation and Neuroplastic Window Dynamics · 中文
Chapter 7. Classical Sources Read Side by Side: “Begin Like a Millet Grain” and the Boundary of Dose
Note
Every comparison here is an analogy, and nothing in this chapter can be acted on. The chapter analyses classical texts as algorithms and propositions. It does not use them to support any modern practice and does not translate ancient usage into advice. The “dose-finding rule” discussed here is studied as an algorithm on a synthetic population; it concerns no substance, and no one should use it to choose an amount of anything.
The three grades and “lightening the body, extending the years”
Source text
The preface of the Shennong Bencao Jing divides drugs into three grades. The 120 upper-grade drugs are sovereigns: “they govern the nourishing of life and correspond to heaven; they are without toxicity; taking much of them and taking them long does not harm a person; those who wish to lighten the body, benefit the qi, not grow old and extend their years take the upper classic as their basis.” The middle grade are ministers, “governing the nourishing of the nature and corresponding to man”; the lower grade are assistants and envoys, “governing the treatment of illness and corresponding to earth; they have much toxicity and cannot be taken long” (Shen Nong 1998).
“Lightening the body and extending the years” is the phrase cited in this book’s subtitle. And there is a problem here that has to be stated.
Evidence
The upper grade contains substances now known to be toxic. The first item in the upper grade of the Shennong Bencao Jing is cinnabar, mercuric sulphide. Modern toxicology has examined mercury in traditional medicines specifically: Liu and colleagues note that mercuric sulphide is not toxicologically equivalent to common mercurials such as mercuric chloride or methylmercury, having far lower oral absorption (Liu et al. 2008). But that is not enough to support “taking much of them and taking them long does not harm a person”, still less prolonged taking.
So
the upper grade’s language of absence of toxicity and prolonged taking cannot be treated as historical evidence of safety. It records the judgement of a classificatory system, and that judgement conflicts with modern toxicology in at least one important case.
This bears directly on the book’s subject: if someone appeals to “the ancients said this substance lightens the body and extends the years” in support of long-term low-level use of something, the form of that argument already has a counterexample inside the Bencao Jing’s own upper grade.
“Begin like a millet grain”: a dose-finding algorithm
Another passage of the preface is of an entirely different kind — it is a rule, and rules can be analysed.
Source text
Shennong Bencao Jing, preface: “If a toxic drug is used to treat illness, begin with an amount like a millet grain; if the illness goes, stop; if it does not go, double it; if it still does not go, make it tenfold; take the removal of the illness as the measure.” (Shen Nong 1998)
That passage has every element of an algorithm: a starting dose (the smallest feasible amount), a stopping rule (stop when the illness goes), an escalation rule (double, then tenfold) and a terminating criterion (removal of the illness as the measure). And dose-finding algorithms have operating characteristics that can be computed.
Evidence
Modern dose-finding designs. Storer set out the design and analysis of phase I clinical trials systematically, including the family of rules now generally called “3+3” (Storer 1989). O’Quigley, Pepe and Fisher proposed the continual reassessment method, which feeds observed toxicity back into the choice of the next dose through a one-parameter model (O’Quigley, Pepe, and Fisher 1990). Both escalate on toxicity, and both learn at the level of a population.
Calculation
# Chapter 7. The Shennong Bencao Jing's escalation rule, treated as an
# algorithm. The preface to the Bencao Jing instructs, for toxic drugs: begin
# with an amount "like a millet grain"; if the illness goes, stop; if it does
# not, double it; if it still does not, go tenfold; take the removal of the
# illness as the measure. That is a dose-finding rule, and dose-finding rules
# have operating characteristics. The program compares it with a modern 3+3
# design and a one-parameter continual reassessment method on the same
# synthetic patient population, and reports what each finds and what each
# costs. Everything is in dose-fraction units relative to an unspecified
# reference. Synthetic; fixed seed; standard library only. This is a study of
# the RULE, not advice to use it.
import math
import random
# 0.05 .. 12.8, dimensionless
DOSE_LEVELS = [0.05 * (2 ** k) for k in range(9)]
def p_toxic(d, d50=3.0, slope=1.6):
return 1.0 / (1.0 + (d50 / d) ** slope)
def p_effective(d, d50=0.8, slope=1.8):
return 1.0 / (1.0 + (d50 / d) ** slope)
def classical(rng, max_steps=12):
"""Begin minimal; stop if effective; else double; if still not, go
tenfold."""
d, used, doubled = DOSE_LEVELS[0], 0, 0
tox = False
for _ in range(max_steps):
used += 1
if rng.random() < p_toxic(d):
tox = True
break
if rng.random() < p_effective(d):
return d, used, tox
if doubled < 2:
d *= 2.0
doubled += 1
else:
d *= 10.0
doubled = 0
if d > DOSE_LEVELS[-1]:
break
return d, used, tox
def three_plus_three(rng, target=0.33):
"""Classic 3+3: escalate while 0/3, expand on 1/3, stop on >=2."""
exposures = 0
for i, d in enumerate(DOSE_LEVELS):
t = sum(1 for _ in range(3) if rng.random() < p_toxic(d))
exposures += 3
if t == 0:
continue
if t == 1:
t2 = sum(1 for _ in range(3) if rng.random() < p_toxic(d))
exposures += 3
if t + t2 <= 1:
continue
return (
(DOSE_LEVELS[i - 1] if i > 0 else DOSE_LEVELS[0]),
exposures,
True,
)
return DOSE_LEVELS[-1], exposures, False
def crm(rng, n=24, target=0.25):
"""One-parameter power model CRM on a skeleton, grid posterior over
beta."""
skeleton = [p_toxic(d) for d in DOSE_LEVELS]
betas = [0.2 * (10 ** (0.05 * k)) for k in range(41)]
logpost = [0.0] * len(betas)
idx, exposures, tox_total = 0, 0, 0
for _ in range(n):
d = DOSE_LEVELS[idx]
y = 1 if rng.random() < p_toxic(d) else 0
exposures += 1
tox_total += y
for bi, b in enumerate(betas):
p = min(max(skeleton[idx] ** b, 1e-9), 1 - 1e-9)
logpost[bi] += math.log(p) if y else math.log(1 - p)
m = max(logpost)
w = [math.exp(v - m) for v in logpost]
s = math.fsum(w)
w = [v / s for v in w]
best, bestgap = 0, 9e9
for j in range(len(DOSE_LEVELS)):
est = math.fsum(
wi * (skeleton[j] ** b) for wi, b in zip(w, betas)
)
if abs(est - target) < bestgap:
best, bestgap = j, abs(est - target)
idx = min(best, idx + 1) # no skipping upward
return DOSE_LEVELS[idx], exposures, tox_total > 0
if __name__ == "__main__":
print(
"Dose levels (dimensionless fractions of an unspecified reference):"
)
print(" " + " ".join("{:.2f}".format(d) for d in DOSE_LEVELS))
print(
"\nSynthetic population: P(toxic) has its midpoint at 3.00 and"
" P(effective)"
)
print(
"at 0.80, so there is a real therapeutic window. Target toxicity"
" 25 %."
)
print(" dose P(effective) P(toxic)")
for d in DOSE_LEVELS[:7]:
print(
" {:5.2f} {:14.3f} {:10.3f}".format(
d, p_effective(d), p_toxic(d)
)
)
REPS = 3000
print("\n{} simulated dose-findings per rule.\n".format(REPS))
print(" rule median dose found mean exposures"
" any toxicity")
for name, fn in (("Bencao Jing escalation", classical),
("3+3", three_plus_three),
("CRM, 24 patients", crm)):
rng = random.Random(777)
doses, exps, toxes = [], [], 0
for _ in range(REPS):
d, e, t = fn(rng)
doses.append(d)
exps.append(e)
toxes += t
doses.sort()
print(
" {:24s} {:16.2f} {:15.1f} {:13.1%}".format(
name, doses[REPS // 2], math.fsum(exps) / REPS, toxes / REPS
)
)
print(
"\n The three columns are not like for like, and that matters. The"
)
print(
" classical rule is a rule for ONE person, so its exposure count"
" is one"
)
print(
" person's escalation and its toxicity column is that person's"
" risk. The"
)
print(
" 3+3 and the CRM are trial-level designs run across many people,"
" so their"
)
print(
" exposure counts are totals and 'any toxicity' is near-certain"
" simply"
)
print(
" because twenty-odd people were exposed. The comparison is"
" informative"
)
print(" about the SHAPE of each rule, not about which is safer.")
print(
"\nThe classical rule reaches a dose near the effective midpoint with"
" very"
)
print(
"few exposures, because it escalates against the RESPONSE rather than"
)
print(
"against toxicity, and it stops the moment the illness goes. That"
" is its"
)
print(
"strength: it is individualised and it is frugal. Its weakness is"
" also"
)
print(
"visible: it has no mechanism for learning across people, so each"
" person"
)
print(
"repeats the whole search, and the tenfold step after two"
" doublings is"
)
print("large enough to cross a steep toxicity curve in one move.")
print("\nWhat the tenfold step costs, measured as P(toxic) at each step:")
d = DOSE_LEVELS[0]
seq = [d]
for k in range(4):
seq.append(seq[-1] * 2)
seq.append(seq[-1] * 10)
print(" step dose P(toxic) increment in P(toxic)")
prev = 0.0
for i, dd in enumerate(seq):
pt = p_toxic(dd)
print(
" {:5d} {:7.2f} {:10.4f} {:22.4f}".format(i, dd, pt, pt - prev)
)
prev = pt
print(
"\n The doublings move P(toxic) by small amounts; the single"
" tenfold step"
)
print(
" moves it by much more than all the doublings combined. Read as an"
)
print(
" algorithm, the rule is therefore well designed in its early"
" phase and"
)
print(
" badly designed in its last step - which is exactly the kind of"
" judgement"
)
print(" a formal comparison can offer and a reverent reading cannot.")
print(
"\n This is an analysis of a RULE on synthetic data. It is not a"
" claim"
)
print(
" about any substance, and nothing here should be used to choose an"
" amount"
)
print(" of anything.")
# Dose levels (dimensionless fractions of an unspecified reference):
# 0.05 0.10 0.20 0.40 0.80 1.60 3.20 6.40 12.80
#
# Synthetic population: P(toxic) has its midpoint at 3.00 and P(effective)
# at 0.80, so there is a real therapeutic window. Target toxicity 25 %.
# dose P(effective) P(toxic)
# 0.05 0.007 0.001
# 0.10 0.023 0.004
# 0.20 0.076 0.013
# 0.40 0.223 0.038
# 0.80 0.500 0.108
# 1.60 0.777 0.268
# 3.20 0.924 0.526
#
# 3000 simulated dose-findings per rule.
#
# rule median dose found mean exposures any toxicity
# Bencao Jing escalation 2.00 3.9 38.5%
# 3+3 0.80 22.2 100.0%
# CRM, 24 patients 1.60 24.0 100.0%
#
# The three columns are not like for like, and that matters. The
# classical rule is a rule for ONE person, so its exposure count is one
# person's escalation and its toxicity column is that person's risk. The
# 3+3 and the CRM are trial-level designs run across many people, so their
# exposure counts are totals and 'any toxicity' is near-certain simply
# because twenty-odd people were exposed. The comparison is informative
# about the SHAPE of each rule, not about which is safer.
#
# The classical rule reaches a dose near the effective midpoint with very
# few exposures, because it escalates against the RESPONSE rather than
# against toxicity, and it stops the moment the illness goes. That is its
# strength: it is individualised and it is frugal. Its weakness is also
# visible: it has no mechanism for learning across people, so each person
# repeats the whole search, and the tenfold step after two doublings is
# large enough to cross a steep toxicity curve in one move.
#
# What the tenfold step costs, measured as P(toxic) at each step:
# step dose P(toxic) increment in P(toxic)
# 0 0.05 0.0014 0.0014
# 1 0.10 0.0043 0.0029
# 2 0.20 0.0130 0.0086
# 3 0.40 0.0383 0.0253
# 4 0.80 0.1077 0.0694
# 5 8.00 0.8277 0.7200
#
# The doublings move P(toxic) by small amounts; the single tenfold step
# moves it by much more than all the doublings combined. Read as an
# algorithm, the rule is therefore well designed in its early phase and
# badly designed in its last step - which is exactly the kind of judgement
# a formal comparison can offer and a reverent reading cannot.
#
# This is an analysis of a RULE on synthetic data. It is not a claim
# about any substance, and nothing here should be used to choose an amount
# of anything.Note
The three columns are not comparable quantities. The Bencao Jing’s rule is a rule for one person, so its exposure count is one person’s escalation and its toxicity column is that person’s risk; the 3+3 and the continual reassessment method are trial-level designs run across many people, so their exposure counts are totals and “any toxicity” is near-certain simply because twenty-odd people were exposed. The comparison is informative about the shape of the three rules, not about which is safer.
The result has two sides.
The strength of the Bencao Jing’s rule. It escalates on response (the illness going) rather than on toxicity, and it stops the moment a response appears. That makes it individualised and frugal — on this synthetic population it reaches a dose near the effective midpoint in about 3.9 exposures, against 22.2 and 24.0 for the 3+3 and the continual reassessment method. “Take the removal of the illness as the measure” is an explicit stopping rule, which every dose-finding design needs and which many pieces of self-experimentation conspicuously lack.
Its weakness. It has no mechanism for learning across people, so each person repeats the whole search; and by the program’s second table the final tenfold step raises the probability of toxicity by an increment (0.7200) greater than all the doublings combined (0.0014 + 0.0029 + 0.0086 + 0.0253 + 0.0694 = 0.1076).
Read as an algorithm, the rule is well designed in its doubling phase and badly designed in its last step.
That is exactly the sort of judgement a formal comparison can offer and a reverent reading cannot. One qualification is worth adding: the text says to go tenfold only when doubling has failed, so that step is taken in a situation where two attempts have already produced nothing, and accepting more risk there is defensible. But the magnitude of the risk is as the table shows, and that is something the original text had no way to know.
Paracelsus and the biphasic curve
Source text
Paracelsus (1493–1541) is usually summarised as holding that the dose makes the poison: all things are poison and nothing is without poison; only the dose makes a thing not a poison. Borzelleca has assessed Paracelsus’s place in modern toxicology (Borzelleca 2000).
The Bencao Jing’s “take the removal of the illness as the measure” and Paracelsus’s proposition stand on the same side structurally: both move the basis of judgement from the substance to the amount. And neither says what the amount should be — that requires a curve.
Writing “benefit” and “harm” as the difference of two saturating curves gives a biphasic, inverted-U dose-response. That is the form of hormesis, which Calabrese and Baldwin argued is more general in toxicology than monotonic models (Calabrese and Baldwin 2003); Volume 30 is devoted to the subject and only one calculation is taken here.
Calculation
# Chapter 7. "Light the body and extend the years" as a biphasic
# dose-response, and why the location of the optimum is the hardest thing to
# measure. A benefit term saturates while a cost term grows with a steeper
# slope:
# net(d) = B d^a / (d^a + kB^a) - C d^b / (d^b + kC^b)
# With b > a the net response is an inverted U: zero at the bottom, a maximum
# somewhere, and negative beyond. Volume 30 treated hormesis in general; what
# this program adds is an uncertainty calculation. Given plausible uncertainty
# in the four parameters, how precisely is the optimum located? The answer
# bounds what any recommendation could be. Dimensionless dose fractions;
# synthetic; fixed seed; standard library only.
import math
import random
def net(d, B=1.0, kB=0.8, a=1.6, C=1.0, kC=4.0, b=3.0):
if d <= 0:
return 0.0
ben = B * d ** a / (d ** a + kB ** a)
cost = C * d ** b / (d ** b + kC ** b)
return ben - cost
def optimum(**kw):
grid = [0.02 * (10 ** (0.01 * k)) for k in range(301)] # 0.02 .. 20
best = max(grid, key=lambda d: net(d, **kw))
return best, net(best, **kw)
if __name__ == "__main__":
print("Benefit saturates (exponent 1.6, midpoint 0.8); cost is steeper")
print(
"(exponent 3.0, midpoint 4.0). All in dimensionless dose fractions.\n"
)
print(" dose benefit cost net")
for d in (0.1, 0.3, 0.8, 1.5, 2.5, 4.0, 6.0, 10.0):
ben = 1.0 * d ** 1.6 / (d ** 1.6 + 0.8 ** 1.6)
cost = 1.0 * d ** 3.0 / (d ** 3.0 + 4.0 ** 3.0)
print(
" {:6.2f} {:9.3f} {:7.3f} {:7.3f}".format(
d, ben, cost, ben - cost
)
)
d_opt, v_opt = optimum()
print("\nOptimum at d = {:.3f}, net = {:.3f}".format(d_opt, v_opt))
print(
"\nHow flat is the peak? The range of doses within 5 % and 10 % of"
" the best:"
)
grid = [0.02 * (10 ** (0.005 * k)) for k in range(601)]
for frac in (0.05, 0.10, 0.25):
ok = [d for d in grid if net(d) >= v_opt * (1 - frac)]
print(
" within {:3.0%} of best: {:.3f} to {:.3f} (a factor of {:.2f})"
.format(frac, min(ok), max(ok), max(ok) / min(ok))
)
print(
"\nNow the uncertainty. Each of the four parameters is given a modest"
)
print("log-normal uncertainty (30 % CV) and the optimum is recomputed:")
rng = random.Random(5213)
opts = []
for _ in range(2000):
kw = dict(kB=0.8 * math.exp(rng.gauss(0, 0.29)),
a=1.6 * math.exp(rng.gauss(0, 0.29)),
kC=4.0 * math.exp(rng.gauss(0, 0.29)),
b=3.0 * math.exp(rng.gauss(0, 0.29)))
opts.append(optimum(**kw)[0])
opts.sort()
print(" median optimum {:.3f}".format(opts[len(opts) // 2]))
print(" 5th to 95th percentile {:.3f} to {:.3f} (a factor of {:.1f})"
.format(opts[len(opts) // 20], opts[-len(opts) // 20],
opts[-len(opts) // 20] / opts[len(opts) // 20]))
print(
"\n A 30 % uncertainty in the parameters becomes a factor of"
" roughly {:.0f}".format(
opts[-len(opts) // 20] / opts[len(opts) // 20]
)
)
print(
" in the location of the optimum. That is the quantitative reason a"
" dose"
)
print(
" recommendation cannot be derived from a dose-response shape that"
" has not"
)
print(
" been measured: the optimum is the least identifiable feature"
" of the"
)
print(
" curve, because it depends on the DIFFERENCE of two uncertain"
" terms."
)
print(
"\nThe asymmetry of being wrong. Net response at multiples of the"
" optimum:"
)
print(" multiple of optimum dose net fraction of best")
for mult in (0.25, 0.5, 1.0, 2.0, 3.0, 4.0):
d = d_opt * mult
print(" {:19.2f} {:7.3f} {:7.3f} {:17.1%}"
.format(mult, d, net(d), net(d) / v_opt))
print(
"\n A quarter of the optimum keeps {:.0%} of the benefit; four"
" times it".format(net(d_opt * 0.25) / v_opt)
)
print(
" gives {:.0%}. The curve is far more forgiving below the optimum"
" than".format(net(d_opt * 4.0) / v_opt)
)
print(
" above it, which is the formal content of the classical"
" instruction to"
)
print(
" begin with the smallest possible amount and increase only if"
" needed."
)
print(
" Note that this conclusion depends on b > a - on the cost curve"
" being"
)
print(
" steeper than the benefit curve - which is an assumption of the"
" model,"
)
print(" not a measurement.")
# Benefit saturates (exponent 1.6, midpoint 0.8); cost is steeper
# (exponent 3.0, midpoint 4.0). All in dimensionless dose fractions.
#
# dose benefit cost net
# 0.10 0.035 0.000 0.035
# 0.30 0.172 0.000 0.172
# 0.80 0.500 0.008 0.492
# 1.50 0.732 0.050 0.682
# 2.50 0.861 0.196 0.665
# 4.00 0.929 0.500 0.429
# 6.00 0.962 0.771 0.190
# 10.00 0.983 0.940 0.043
#
# Optimum at d = 1.867, net = 0.703
#
# How flat is the peak? The range of doses within 5 % and 10 % of the best:
# within 5% of best: 1.400 to 2.461 (a factor of 1.76)
# within 10% of best: 1.219 to 2.729 (a factor of 2.24)
# within 25% of best: 0.883 to 3.396 (a factor of 3.85)
#
# Now the uncertainty. Each of the four parameters is given a modest
# log-normal uncertainty (30 % CV) and the optimum is recomputed:
# median optimum 1.867
# 5th to 95th percentile 1.233 to 2.825 (a factor of 2.3)
#
# A 30 % uncertainty in the parameters becomes a factor of roughly 2
# in the location of the optimum. That is the quantitative reason a dose
# recommendation cannot be derived from a dose-response shape that has not
# been measured: the optimum is the least identifiable feature of the
# curve, because it depends on the DIFFERENCE of two uncertain terms.
#
# The asymmetry of being wrong. Net response at multiples of the optimum:
# multiple of optimum dose net fraction of best
# 0.25 0.467 0.295 42.0%
# 0.50 0.933 0.549 78.1%
# 1.00 1.867 0.703 100.0%
# 2.00 3.733 0.473 67.3%
# 3.00 5.600 0.225 32.0%
# 4.00 7.466 0.106 15.1%
#
# A quarter of the optimum keeps 42% of the benefit; four times it
# gives 15%. The curve is far more forgiving below the optimum than
# above it, which is the formal content of the classical instruction to
# begin with the smallest possible amount and increase only if needed.
# Note that this conclusion depends on b > a - on the cost curve being
# steeper than the benefit curve - which is an assumption of the model,
# not a measurement.Three results.
First, the peak is flat: the span of doses within 5 % of the optimum covers a factor, and within 10 % a wider one. So “the optimal dose” is not a point.
Second, the location of the optimum is the hardest feature of the curve to determine. Giving each of four parameters a 30 % log-normal uncertainty makes the 5th-to-95th percentile range of the optimum span a factor of 2.3. The reason is that the optimum depends on the difference of two uncertain terms, and the relative error of a difference exceeds that of its parts. So
a dose recommendation cannot be derived from a dose-response shape that has not been measured.
Third, being wrong on the low side is cheaper than being wrong on the high side: a quarter of the optimum retains 42 % of the net benefit, while four times it retains 15 %. That is the formal content of the Bencao Jing’s “begin like a millet grain” and “double it if it does not go” — start small and increase only if needed — and the program also states that this conclusion depends on the cost curve being steeper than the benefit curve (), which is an assumption of the model and not a measurement.
Structural comparison and its limits
| Text | What it supplies | Position in this book’s framework |
|---|---|---|
| Bencao Jing three grades, “lightening the body” | A classificatory judgement | Not evidence of safety; cinnabar in the upper grade is a counterexample |
| Bencao Jing “begin like a millet grain … removal as the measure” | A dose-finding algorithm | Doubling phase sound; the tenfold step raises risk by more than all doublings combined |
| Paracelsus’s thesis on dose | Moves judgement from substance to amount | Same side as “removal as the measure”; neither supplies an amount |
| The biphasic dose-response | The form of the amount | The optimum is the least determinable feature (30 % parameter uncertainty → a factor of 2.3 in location) |
Three limits. First, none of these texts discusses any of the specific pharmacological mechanisms of the first six chapters, so no comparison is attempted there. Second, the Bencao Jing’s “toxic drug” means a toxic drug used to treat illness, not for everyday enhancement; transferring “begin like a millet grain” to non-therapeutic long-term use goes beyond the situation the text addresses. Third, the algorithmic analysis here is carried out on a synthetic population: it evaluates a rule, not any substance.
Summary
The Shennong Bencao Jing’s upper-grade language — without toxicity, taken much and long without harm, lightening the body and extending the years — cannot be treated as historical evidence of safety: the first upper-grade item is cinnabar, mercuric sulphide, and while modern toxicology finds mercuric sulphide not equivalent to common mercurials, it does not support prolonged taking. The preface’s escalation instruction is by contrast a complete dose-finding algorithm; compared on a synthetic population with a 3+3 design and a continual reassessment method, it escalates on response rather than toxicity, has an explicit stopping rule, and reaches a dose near the effective midpoint in about 3.9 exposures, but has no mechanism for learning across people, and its final tenfold step raises the probability of toxicity by more than all the preceding doublings combined. Paracelsus’s proposition stands on the same side as “removal as the measure”: both move judgement from substance to amount, and neither supplies the amount. Supplying it requires a curve, and the optimum of a biphasic curve is its least determinable feature — a 30 % parameter uncertainty becomes a factor of 2.3 in location — while the curve is more forgiving low than high (42 % of net benefit at a quarter of the optimum, 15 % at four times), which is the formal content of “begin like a millet grain” and depends on the assumption that the cost curve is the steeper.
References
Fan, Y. (2026). Biomathematical Models of Sub-Perceptual Tryptamine Pharmacokinetics, 5-HT2A Receptor Desensitisation and Neuroplastic Window Dynamics: From Michaelis–Menten Kinetics of Prodrug Deacetylation and Whole-Brain Connectivity Entropy to the Microdose Tolerance Ratchet, with a Textual Examination of the Dose Boundary in the Classical Materia Medica [亚知觉色胺药代动力学、5-HT2A 受体脱敏与神经可塑性窗口的生物数学模型] (Version 1.0.0). 5D Library. https://doi.org/10.5281/zenodo.24019347 · Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0).